Schedule 8 Medicinal Cannabis Wholesale

GLG supplies exclusively to B2B entities with the appropriate regulatory standing to receive Schedule 8 medicinal cannabis. This includes dispensing pharmacies registered under AHPRA and holding state-level Schedule 8 dispensing authority, registered medical practitioners with TGA Authorised Prescriber (AP) status or access to the SAS-B pathway, licensed clinics and telehealth providers with in-house or partnered dispensing arrangements, and overseas GMP producers seeking an Australian import and distribution partner. We do not supply to the general public under any circumstances. All prospective accounts are verified prior to supply commencement.

Every GLG wholesale order ships with a complete Schedule 8 documentation package. This includes a wholesale supply record formatted to DDA register requirements, a batch-specific Certificate of Analysis (COA) from an accredited laboratory, the relevant ODC import permit reference and product description, a chain-of-custody document covering storage-to-delivery, and a delivery confirmation form for the receiving authorised person to sign at handover. Digital copies are retained by GLG for the statutory period. The package is designed to require no supplementation for NSW Ministry of Health compliance purposes, though we are always available to provide additional product or permit documentation on request.

Lead times are quoted against confirmed stock positions at our licenced storage facility, not against anticipated import arrivals. For standard orders from stock on hand, domestic delivery lead times typically range from two to five business days depending on the delivery location and logistics scheduling. For orders placed against incoming batches — where a pharmacy or clinic wishes to reserve product from an inbound shipment — we provide estimated availability windows once the relevant ODC import permit has been granted and the shipment is confirmed. We do not quote firm delivery dates until stock has cleared customs and been received into licenced storage.

Schedule 8 stock is tracked at every point of the supply chain using batch-level chain-of-custody documentation. At storage, BLSWM maintains a DDA register covering all Schedule 8 holdings, with reconciliation performed at each stock movement. At dispatch, Peddler Distribution assumes custody under a signed handover record and maintains temperature and tamper-evident integrity throughout transit. At delivery, the receiving authorised person signs the chain-of-custody document, which is returned to GLG and filed against the order record. GLG's internal records link each transaction to the originating ODC import permit, the specific batch COA, and the delivery confirmation, creating a complete, auditable chain from country of origin to the dispensary shelf. This structure is consistent with obligations under the NSW Poisons and Therapeutic Goods Act 1966 and federal Narcotic Drugs Act 1967.

Yes. Dispensing pharmacies are our primary wholesale customer category. We supply registered community pharmacies, hospital pharmacies with appropriate authority, and compounding pharmacies credentialled for Schedule 8 medicinal cannabis. Pharmacies do not need to hold their own importer status to purchase from GLG — our NSW Wholesale Poisons Licence and ODC import permits cover the supply chain from overseas manufacturer to pharmacy dispensary. Pharmacists who need to sight our licence or permit documentation as part of their own supplier due diligence can request copies at any time from our account team.

GLG holds a NSW Wholesale Poisons Licence authorising supply of both Schedule 4 (prescription medicine) and Schedule 8 (controlled drug) substances. In the context of medicinal cannabis, Schedule 4 applies to lower-THC products and certain CBD formulations, while Schedule 8 applies to products containing THC above the Schedule 4 threshold. Our current stock and formulary spans both schedules. All Schedule 8 supply is subject to the additional documentation, storage and chain-of-custody requirements described throughout this page. Copies of our licence can be provided to pharmacies and clinics for their supplier records on request.

All medicinal cannabis stock is held at BLSWM's licenced storage facility under conditions consistent with the product-specific storage requirements detailed in each batch's COA and, where applicable, TGA product registration documentation. Schedule 8 stock is stored in compliant controlled-drug storage in accordance with NSW regulatory requirements. Temperature and humidity monitoring is maintained continuously, with records available on request. Cold-chain integrity is maintained through to delivery using temperature-controlled packaging and monitored transit. Any deviation from required storage conditions — whether in storage or during transit — is documented and disclosed to the account holder prior to or at the time of delivery.

Contact us through our enquiry form and indicate that you are seeking a wholesale account. We will respond within one business day to initiate the onboarding process. You will be asked to provide evidence of your pharmacy registration or medical practitioner credentials, your applicable Schedule 8 dispensing or prescribing authority, and your registered delivery address. The verification process typically takes two to five business days. Once complete, your account is activated and you can access our formulary and place your first order. There are no onboarding fees or minimum spend commitments required to establish an account.